- Front Research
- Posts
- Carasent (CARA): Poised for Stronger Growth with Increased Sales Volumes and Controlled Costs
Carasent (CARA): Poised for Stronger Growth with Increased Sales Volumes and Controlled Costs
Ticker: CARA | Price: 11 NOK | Price target: 26 NOK | Timeframe: 12 months | Source: Redeye π» Technology/Software Industry | π Growth Poised | π Bullish idea
Disclaimer - Not Investment Advice
The content on Front Research is for informational purposes only and should not be considered as investment advice financial advice. One should always consult a qualified professional before making any investment decisions. Investments carry risks, including the potential loss of capital. Front Research and its authors bear no liability for decisions made based on the information provided here. All views are personal and not reflective of any company mentioned. Front Research, itβs affilaites, personnel, clients and/or partners might hold investments in securites discussed.
By accessing Front Research, you acknowledge and agree to this disclaimer.
STOCK IDEA - Carasent
Carasent (CARA): Poised for Stronger Growth with Increased Sales Volumes and Controlled Costs
Carasent, traded in Norway, is highlighted as a promising investment due to its strong growth prospects, driven by increased sales and controlled costs. The Q4 2023 report revealed a 13% year-on-year increase in Annual Recurring Revenue (ARR) to NOK239m, with a revenue backlog of NOK8m showcasing sales momentum. Despite slightly lower margins, the period marked a record in new sales. With optimistic management and planned product launches in 2024, Carasent is expected to reach a positive EBITDA-CAPEX margin by late 2024. The valuation remains at NOK 11-43, with a base case of NOK 26. Investors are cautioned about the potential impact of a German acquisition, not included in the current estimates. Carasent's appeal lies in its ability to enhance healthcare processes and scalability, underpinned by its significant customer base and potential for network effects and customer loyalty.
Ticker: CARA | Price: 11 NOK | Price target: 26 NOK | Timeframe: 12 months | Source: Redeye
π» Technology/Software Industry | π Growth Poised | π Bullish idea
π Analysis: Dig deeper into this stock idea: Financials, valuation, moat analysis, timing, and moreβ¦upgrade to Limited Partner for access, only $14 per month.
Reply